• 1. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 2. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 3. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 4. Alternative mixtures to R-600a. Theoretical assessment and experimental energy evaluation of binary mixtures in a commercial cooler: Mélanges alternatifs au R-600a. évaluation théorique et évaluation énergétique expérimentale de mélanges binaires dans un refroidisseur commercial.
  DanielCalleja-Anta,DanielSánchez,LauraNebot-Andres,RamónCabello,RodrigoLlopis
• 5. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Toluenes

Comprehensive Overview of 1-(4-Methylbenzyl)cyclopropanamine hydrochloride (CAS No. 29813-00-1)

1-(4-Methylbenzyl)cyclopropanamine hydrochloride (CAS No. 29813-00-1) is a specialized organic compound with a unique cyclopropane ring structure, widely utilized in pharmaceutical research and fine chemical synthesis. Its molecular formula, C₁₁H₁₆N·HCl, highlights its potential as a building block for bioactive molecules. The compound's cyclopropanamine moiety is particularly noteworthy, as it often enhances metabolic stability and binding affinity in drug design. Researchers frequently explore derivatives of this compound for their potential applications in central nervous system (CNS) therapeutics and enzyme modulation.

In recent years, the demand for 1-(4-Methylbenzyl)cyclopropanamine hydrochloride has surged due to its relevance in developing novel small-molecule inhibitors and neurotransmitter analogs. A trending topic in scientific forums involves its role in optimizing drug-likeness properties, a key focus area for medicinal chemists. The compound's hydrochloride salt form improves solubility, making it advantageous for preclinical studies. Analytical techniques like HPLC and NMR are commonly employed to verify its purity, which typically exceeds 98% in commercial batches.

The synthesis of CAS 29813-00-1 typically involves a multi-step process starting from 4-methylbenzyl chloride, followed by cyclopropanation and amine functionalization. This methodology aligns with green chemistry principles when catalytic methods are applied—a hot topic in sustainable pharmaceutical manufacturing. Users searching for "cyclopropanamine derivatives solubility" or "amine hydrochloride stability" often encounter this compound in literature discussing pH-dependent degradation kinetics.

From a commercial perspective, 1-(4-Methylbenzyl)cyclopropanamine HCl is cataloged by major chemical suppliers as a research-grade reagent. Its storage recommendations (2-8°C under inert atmosphere) reflect standard practices for amine-containing compounds. Interestingly, patent databases reveal its structural motif in several investigational drugs targeting G-protein-coupled receptors (GPCRs)—a dominant theme in 2024's drug discovery landscape. This connection makes it a frequent subject in queries like "GPCR ligand synthesis" or "aromatic cyclopropanamine applications."

Quality control protocols for 29813-00-1 emphasize residual solvent analysis via GC-MS, addressing growing regulatory concerns about impurity profiles. The compound's logP value (predicted ~2.1) positions it favorably within Lipinski's rule of five, explaining its popularity in lead optimization workflows. Recent publications also explore its crystalline polymorphism—a critical factor in formulation development that responds to searches like "amine hydrochloride crystallization."

In biological contexts, the 4-methylbenzyl group in this compound demonstrates interesting π-stacking potential with aromatic amino acids, a feature leveraged in structure-activity relationship (SAR) studies. Computational chemists frequently model its conformational flexibility when investigating molecular docking scenarios. These applications correlate with high-search-volume terms such as "rigid amine scaffolds" and "bioisosteric replacement strategies."

Transportation and handling of 1-(4-Methylbenzyl)cyclopropanamine hydrochloride comply with standard laboratory safety protocols. While not classified as hazardous under GHS criteria, proper PPE (gloves, goggles) is recommended during manipulation—a detail often sought in "amine hydrochloride handling precautions" searches. The compound's MSDS data typically highlights its stability under recommended storage conditions, with no significant incompatibilities beyond typical amine reactivity.

Emerging applications include its use as a chiral auxiliary in asymmetric synthesis, responding to industry demand for enantioselective catalysts. This aligns with the broader market trend toward stereochemically pure intermediates. Analytical method development for this compound often focuses on chiral separation techniques—a topic generating substantial academic interest, as seen in queries like "HPLC method for cyclopropanamine resolution."

In summary, CAS 29813-00-1 represents a versatile scaffold bridging medicinal chemistry and material science. Its balanced physicochemical properties and structural rigidity continue to inspire innovation across multiple research domains, from fragment-based drug discovery to advanced material design. The compound's recurring appearance in recent patent filings suggests sustained relevance in cutting-edge therapeutic development.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)